RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Simulations Plus, Inc. (Nasdaq: SLP) (“Simulations Plus” or the “Company”), a global leader in model-informed and AI-accelerated drug development that ...
Unfortunately, this book can't be printed from the OpenBook. If you need to print pages from this book, we recommend downloading it as a PDF. Visit NAP.edu/10766 to get more information about this ...
Alzheimer’s disease (AD) and related dementias (ADRD) remain major unmet medical needs, in part because disease mechanisms span multiple interacting ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results